Expertise in
3
conditions

Donald J. Fraser

Heath Park, 
Cardiff, WLS, GB 
Expertise in
3
conditions
Heath Park, 
Cardiff, WLS, GB 
OverviewLocationsClinical Research

Overview

Donald Fraser practices in Cardiff, United Kingdom. Mr. Fraser is highly rated in 3 conditions, according to our data. His top areas of expertise are Secondary Peritonitis, Peritonitis, Diabetic Nephropathy, Wilson Disease, and Kidney Transplant.

His clinical research consists of co-authoring 62 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Heath Park, Cardiff, WLS, United Kingdom
Other Locations
University Of Warwick Science Park, Coventry, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
Enrollment Status: Completed
Publish Date: April 02, 2024
Intervention Type: Drug
Study Drugs: Daprodustat, Darbepoetin Alpha
Study Phase: Phase 3
A Phase 2, Multi-Center, Randomised, Double-Blind, Ascending-Dose, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of Fostamatinib in the Treatment of IgA Nephropathy
A Phase 2, Multi-Center, Randomised, Double-Blind, Ascending-Dose, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of Fostamatinib in the Treatment of IgA Nephropathy
Enrollment Status: Completed
Publish Date: June 27, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

62 Total Publications

Unravelling Impact of Comorbidities on Mortality Risks in CKD Patients During the COVID-19 Pandemic: An Explainable AI-Driven Study.
Unravelling Impact of Comorbidities on Mortality Risks in CKD Patients During the COVID-19 Pandemic: An Explainable AI-Driven Study.
Journal: Annals of epidemiology
Published: November 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Fraser's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile